FMT and Other Gut Microbial Therapies

Overview

About this study

The purpose of this study is to expand knowledge and optimize practice in the transplantation of fecal microbiota or other Gut Microbial Therapies.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Recipient Inclusion Criteria

Ability to give informed consent.
Receiving an FMT or other GMT within 90 days after providing consent.
Access to internet and/or telephone.

Donor Inclusion

Ability to give informed consent.
Providing stool sample for FMT.

Subject Exclusion Criteria

Incarceration.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 5/13/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Sahil Khanna, M.B.B.S., M.S.	Open for enrollment	Contact information: Rebecca Hofschulte CCRP (507) 284-9709 rstcdiffstudyappt@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Sahil Khanna, M.B.B.S., M.S.

Open for enrollment

Contact information:

Rebecca Hofschulte CCRP

(507) 284-9709

rstcdiffstudyappt@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials